Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1006 AL 1020

The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis

Liu S, Zeng F, Wang C, Chen Z, Zhao B, Li K.

Sci Rep. 2015 Sep 4;5:13598. doi: 10.1038/srep13598.

What can lipidomics tell us about the pathogenesis of Alzheimer disease?

Xiang Y, Lam SM, Shui G.

Biol Chem. 2015 Dec;396(12):1281-91. doi: 10.1515/hsz-2015-0207.

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

Palmqvist S, Zetterberg H, Mattsson N, Johansson P; Alzheimer's Disease Neuroimaging Initiative; Minthon L, Blennow K, Olsson M, Hansson O; Swedish BioFINDER Study Group.

Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.

A simulation system for biomarker evolution in neurodegenerative disease

Young AL, Oxtoby NP, Ourselin S, Schott JM, Alexander DC; Alzheimer's Disease Neuroimaging Initiative.

Med Image Anal. 2015 Dec;26(1):47-56. doi: 10.1016/j.media.2015.07.004. Epub 2015 Aug 15.

Lipidomics of human brain aging and Alzheimer's disease pathology

Naudí A, Cabré R, Jové M, Ayala V, Gonzalo H, Portero-Otín M, Ferrer I, Pamplona R.

Int Rev Neurobiol. 2015;122:133-89. doi: 10.1016/bs.irn.2015.05.008. Epub 2015 Jun 19.

Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease

Lee SL, Thomas P, Fenech M.

Mutat Res. 2015 Jun;776:54-83. doi: 10.1016/j.mrfmmm.2014.12.012. Epub 2015 Jan 17.

Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology

Ishii M, Iadecola C.

Cell Metab. 2015 Nov 3;22(5):761-76. doi: 10.1016/j.cmet.2015.08.016. Epub 2015 Sep 10.

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention

Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.

Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351. Epub 2015 Sep 23.

Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models

Kincses ZT, Király A, Veréb D, Vécsei L.

J Alzheimers Dis. 2015;47(2):277-90. doi: 10.3233/JAD-143195.

Biomarkers in Sporadic and Familial Alzheimer's Disease

Lista S, O'Bryant SE, Blennow K, Dubois B, Hugon J, Zetterberg H, Hampel H.

J Alzheimers Dis. 2015;47(2):291-317. doi: 10.3233/JAD-143006.

Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject

Tiepolt S, Patt M, Hoffmann KT, Schroeter ML, Sabri O, Barthel H.

J Alzheimers Dis. 2015;47(3):539-43. doi: 10.3233/JAD-150163.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

A Novel Plasma Based Biomarker of Alzheimer's Disease

Bradley-Whitman MA, Abner E, Lynn BC, Lovell MA.

J Alzheimers Dis. 2015;47(3):761-71. doi: 10.3233/JAD-150183.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias